Form 4: Natera Co-Founder Jonathan Sheena Files Planned Stock Sale Under Rule 10b5-1

Natera, Inc. Director and Co-Founder Jonathan Sheena has filed a Form 4 indicating a future sale of 3,070 shares of common stock on July 16, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Jonathan Sheena, a Co-Founder and Director of Natera, Inc. (NTRA), reported a planned sale of 3,070 shares of common stock.
• The transaction is scheduled to occur on July 16, 2025.
• The shares are to be sold at a weighted average price of $149.9635 per share, with individual sales ranging from $149.59 to $150.52.
• The sale is being executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Sheena on December 11, 2024.
• Following this planned transaction, Mr. Sheena will directly own 245,704 shares of Natera common stock.
• Additionally, 35,782 shares are held indirectly by Caraluna 1 Trust and 35,782 shares by Caraluna 2 Trust, for which Mr. Sheena disclaims beneficial ownership.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While an insider sale can sometimes be viewed negatively, this transaction is part of a pre-arranged Rule 10b5-1 plan adopted several months prior to the planned sale date. This suggests a scheduled liquidity event for personal financial planning rather than a reaction to new, negative company developments.

Negatives

• The planned sale of 3,070 shares by a co-founder and director could be perceived by some investors as a slight negative signal, despite being part of a pre-arranged plan.

Risks

• Insider selling, even when pre-planned, can sometimes be misinterpreted by the market, potentially leading to negative sentiment or short-term price volatility.

Future Outlook

The document details a pre-planned future stock sale by an insider, which is typically for personal financial planning and does not provide forward-looking statements or guidance regarding the company's operational or financial performance.

Industry Context

This Form 4 filing is specific to an insider transaction at Natera, Inc. and does not provide information directly related to broader industry trends or competitive landscape. Insider trading activity is a common occurrence across all industries, often reflecting individual financial planning rather than company-specific performance signals, especially when conducted under a Rule 10b5-1 plan.

Related Party Transactions

• Shares are held indirectly for the benefit of beneficiaries of Caraluna 1 Trust and Caraluna 2 Trust, for which the reporting person disclaims beneficial ownership.

Stakeholder Impact

• Shareholders: The planned sale by a co-founder and director may lead to minor shifts in investor sentiment, though the Rule 10b5-1 plan mitigates concerns about immediate negative implications for the company's outlook.

Next Steps

• The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the reported range upon written request.

Key Dates

Recommendation

Keywords

Natera, NTRA, Form 4, Insider Trading, Stock Sale, Jonathan Sheena, Rule 10b5-1, Director, Co-Founder, Equity Transaction